Press release
Top Factor Driving Epigenetics Drugs And Diagnostic Technologies Market Growth in 2025: Rising Cancer Rates Drive Demand For Advanced Epigenetic Solutions
Epigenetics Drugs And Diagnostic Technologies Market Size
The anticipated rise in cancer cases is predicted to spur the expansion of the market for epigenetics drugs and diagnostic technologies. Cancer is a group of diseases characterized by abnormal cellular growth that holds the potential to encroach or spread to other bodily regions. Factors such as an ageing population, changes in lifestyle, environmental pollution, genetic risks, and advanced diagnostic methods are responsible for the surge in cancer prevalence. By targeting and altering gene expression, epigenetic drugs and diagnostic technologies offer a solution to this growing cancer prevalence, paving the way for early detection and custom treatment plans. For instance, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that the diagnosed cancer cases in Australia increased from 156,781 in 2021 to 160,570 in 2022 in July 2024. Thus, the escalating incidence of cancer propels the growth of the market for epigenetics drugs and diagnostic technologies.
Get Your Epigenetics Drugs And Diagnostic Technologies Market Report Here:
https://www.thebusinessresearchcompany.com/report/epigenetics-drugs-and-diagnostic-technologies-global-market-report
What growth opportunities are expected to drive the epigenetics drugs and diagnostic technologies market's CAGR through 2034?
The market size for epigenetics drugs and diagnostic technologies has seen exponential growth in recent years. The market, which is expected to expand from $15.49 billion in 2024 to $18.86 billion in 2025, will see a compound annual growth rate (CAGR) of 21.8%. Factors contributing to this historical growth pattern include increased knowledge of epigenetic mechanisms, progress in genome-wide association studies (GWAS), heightened healthcare demand, a surge in the geriatric population, and a growing prevalence of cancer.
The market for epigenetics drugs and diagnostic technologies is projected to undergo significant expansion in the coming years. It's expected to reach a size of $41.03 billion by 2029, with a compound annual growth rate (CAGR) of 21.4%. The anticipated growth over the forecast duration can be credited to factors such as the escalating incidences of neurological conditions, a rise in inflammatory disorders prevalence, the increasing visibility of chronic illnesses, the surging demand for personalised medicine, and the growing knowledge and implementation of epigenetic diagnostics. Key trends within the forecast period include developments in personalized therapies based on epigenetics, the fusion of epigenomics with artificial intelligence, advancements in multi-omics modes of research and clinical practice, and new-age technologies and diagnostic methods.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19418&type=smp
What are the emerging trends shaping the future of the epigenetics drugs and diagnostic technologies market?
Key players in the epigenetics drugs and diagnostic technologies market are striving to create innovative technologies, such as DNA methylation analysis technology, to bolster the accuracy and efficiency of disease detection, fine-tune personalized medical treatments, and broaden our understanding of gene regulation in multiple diseases. DNA methylation analysis technology is a suite of techniques used to study DNA methylation patterns, which is a chemical procedure that adds a methyl group to the DNA's cytosine base. For example, in August 2023, Watchmaker Genomics Inc., an American biotech firm, teamed up with Exact Sciences Corp., an American molecular diagnostics company, to create and market a unique DNA methylation analysis technology known as TET-assisted pyridine borane sequencing (TAPS). This partnership intends to strengthen cancer detection and diagnostic abilities, utilizing Watchmaker's specialism in engineering DNA-altering enzymes to augment TAPS chemistry. This is particularly important for early-stage cancer detection and tracking minimal residual disease (MRD) via liquid biopsies, where DNA methylation patterns act as indicators for health condition.
Which growth-oriented segments of the epigenetics drugs and diagnostic technologies market are leading the industry's development?
The epigenetics drugs and diagnostic technologiesmarket covered in this report is segmented -
1) By Technology: Deoxyribonucleic Acid (DNA) Methylation, Histone Methylation, Histone Acetylation, Large Non Coding Ribonucleic Acid (RNA), MicroRNA Modification, Chromatin Structures
2) By Application: Oncology, Solid Tumors, Liquid Tumors, Non Oncology, Inflammatory Diseases, Metabolic Diseases, Infectious Diseases, Cardiovascular Diseases, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Deoxyribonucleic Acid (DNA) Methylation: Methylation Inhibitors, Methylation Detection Kits, Methylation Profiling Technologies, Bisulfite Sequencing
2) By Histone Methylation: Histone Methyltransferase Inhibitors, Histone Demethylase Inhibitors, Histone Methylation Assays, Chromatin Immunoprecipitation (ChIP) Techniques
3) By Histone Acetylation: Histone Acetyltransferase Inhibitors, Histone Deacetylase Inhibitors (HDACi), Acetylation Detection Kits, Western Blotting for Acetylation
4) By Large Non-Coding Ribonucleic Acid (RNA): lncRNA Expression Profiling, lncRNA Modulation Technologies, lncRNA Detection Kits, Bioinformatics Tools for lncRNA Analysis
5) By MicroRNA Modification: MicroRNA Mimics, MicroRNA Inhibitors, MicroRNA Expression Analysis, MicroRNA Detection Assays
6) By Chromatin Structures: Chromatin Remodeling Agents, Chromatin Accessibility Assays, 3D Chromatin Architecture Technologies, Nuclear Imaging Techniques
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19418
What regions are leading the charge in the epigenetics drugs and diagnostic technologies market?
North America was the largest region in the epigenetics drugs and diagnostic technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics drugs and diagnostic technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the epigenetics drugs and diagnostic technologies market?
Major companies operating in the epigenetics drugs and diagnostic technologies market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Illumina Inc., QIAGEN NV, Exact Sciences Corporation, Abcam PLC, Syndax Pharmaceuticals Inc., Astex Pharmaceuticals Inc., Diagenode LLC, Cisbio Bioassays, 4SC AG, Verogen Inc., Watchmaker Genomics Inc., Oryzon Genomics SA, Cell Centric Ltd., Epiaxis Therapeutics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19418&type=smp
What Is Covered In The Epigenetics Drugs And Diagnostic Technologies Global Market Report?
•Market Size Forecast: Examine the epigenetics drugs and diagnostic technologies market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the epigenetics drugs and diagnostic technologies market for a structured understanding.
•Key Players Overview: Analyze major players in the epigenetics drugs and diagnostic technologies market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the epigenetics drugs and diagnostic technologies market.
•Segment Contributions: Evaluate how different segments drive overall growth in the epigenetics drugs and diagnostic technologies market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the epigenetics drugs and diagnostic technologies market.
•Industry Challenges: Identify potential risks and obstacles affecting the epigenetics drugs and diagnostic technologies market.
•Competitive Landscape: Review strategic developments in the epigenetics drugs and diagnostic technologies market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Factor Driving Epigenetics Drugs And Diagnostic Technologies Market Growth in 2025: Rising Cancer Rates Drive Demand For Advanced Epigenetic Solutions here
News-ID: 3941563 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
